Intestinal Polyps: Clinical Trials

6 trials for Intestinal Polyps, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 22Completed 2

Follow Intestinal Polyps: new trials by email Literature Review of Intestinal Polyps trials Research Report on Intestinal Polyps

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
polyethylene glycol, sodium phosphate, polyethylene glycol + ascorbic acid - Colon Cancer, Inflammatory Bowel Diseases
Phase 3CompletedRegion Skane1472023-02-012024-02-28
An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
Hextend, Lactated Ringers - Crohn's Disease, Ulcerative Colitis
Phase 3CompletedCorewell Health West692007-05-012009-10-21
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy
AQUAVAN® (fospropofol disodium) Injection, Midazolam HCI - Conscious Sedation
Phase 3CompletedEisai Inc.3002006-03-012008-11-07
Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
AQUAVAN® (fospropofol disodium) Injection, Midazolam HCl - Colonoscopy, Colonic Polyps
Phase 2 / Phase 3CompletedEisai Inc.1252005-07-012008-11-07
Evaluation of Computer-assisted, Non-cathartic CT Colonography
non-cathartic CTC - Colonic Polyps
Phase 2 / Phase 3CompletedMassachusetts General Hospital6052005-06-012015-08-05
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
fospropofol disodium - Colonoscopy, Colon Polyps
Phase 3CompletedEisai Inc.2702004-09-012008-11-07

Narrower conditions

Colonic Polyps (6)  ·  Colonic Neoplasms (3)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Diverticulitis (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Inflammatory Bowel Diseases (1)  ·  Rectal Neoplasms (1)

Broader conditions

Pathological Conditions, Anatomical (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Polyps (6)  ·  Colonic Diseases (3)  ·  Colorectal Neoplasms (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Diseases (3)  ·  Intestinal Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Gastroenteritis (2)

Interventions

fospropofol (3)  ·  Injections (2)  ·  Ascorbic Acid (1)  ·  Diatrizoate Meglumine (1)  ·  Hydroxyethyl Starch Derivatives (1)  ·  Iohexol (1)  ·  Midazolam (1)  ·  Polyethylene Glycols (1)  ·  Ringer's Lactate (1)  ·  picosulfate sodium (1)  ·  prucalopride (1)  ·  sodium phosphate (1)

Sponsors

Eisai Inc. (3)  ·  Corewell Health West (1)  ·  Massachusetts General Hospital (1)  ·  Region Skane (1)

Countries

United States (4)  ·  Sweden (1)

Top investigators

Anthony Senagore, MD (1)  ·  Ervin Toth, MD PhD (1)  ·  James Jones, MD, PharmD (1)  ·  James Jones, MD,PharmD (1)  ·  James Jones, PharmD, MD (1)  ·  Michael Zalis, MD (1)

Results publications

PMID 22586008